Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients

Journal of Clinical Biochemistry and Nutrition

Volumn 45, Issue 3, 2009, Pages 355-360

  Bae, Yun Jung ^a   Yeon, Jee Young ^a   Sung, Chung Ja ^a   Kim, Hyun Sook ^a   Sung, Mi Kyung ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Breast cancer; Iron; MDA; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; IRON; MALONALDEHYDE; RETINOL;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IRON BLOOD LEVEL; IRON INTAKE; IRON OVERLOAD; LIFESTYLE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PLASMA; REDUCTION; VITAMIN INTAKE;

EID: 70549095824     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-46     Document Type: Article

References (41)

1. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P.: Global cancer statistics, 2002. CA. Cancer J. Clin., 55, 74-108, 2005.
2. Korea National Cancer Center: Report on the statistics for national cancer incidence 1999-2001. Korea National Cancer Center, 2006.
3. Tappel, A.: Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med. Hypotheses, 68, 562-564, 2007.
4. Aisen, P., Enns, C., and Wessling-Resnick, M.: Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol., 33, 940-959, 2001.
5. Lieu, P.T., Heiskala, M., Peterson, P.A., and Yang, Y.: The roles of iron in health and disease. Mol. Aspects. Med, 22, 1-87, 2001.
6. McCord, J.M.: Iron, free radicals, and oxidative injury. Semin. Hematol., 35, 5-12, 1998.
7. Huang, X.: Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat. Res., 533, 153-171, 2003.
8. Khanzode, S.S., Muddeshwar, M.G., Khanzode, S.D., and Dakhale, G.N.: Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic. Res., 38, 81-85, 2004.
9. Klaunig, J.E., Xu, Y., Isenberg, J.S., Bachowski, S., Kolaja, K.L., Jiang, J., Stevenson, D.E., and Walborg, E.F. Jr.: The role of oxidative stress in chemical carcinogenesis. Environ. Health Perspect., 106, 289-295, 1998.
10. Malins, D.C., Polissar, N.L., and Gunselman, S.J.: Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc. Natl. Acad. Sci. USA, 93, 2557-2563, 1996.
11. Cavalieri, E., Chakravarti, D., Guttenplan, J., Hart, E., Ingle, J., Jankowiak, R., Muti, P., Rogan, E., Russo, J., Santen, R., and Sutter, T.: Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta, 1766, 63-78, 2006.
12. Liehr, J.G. and Jones, J.S.: Role of iron in estrogen-induced cancer. Curr. Med. Chem., 8, 839-849, 2001.
13. Kallianpur, A.R., Lee, S.A., Gao, Y.T., Lu, W., Zheng, Y., Ruan, Z.X., Dai, Q., Gu, K., Shu, X.O., and Zheng, W.: Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res. Treat., 107, 123-132, 2008.
14. Cade, J., Thomas, E., and Vail, A.: Case-control study of breast cancer in south east England: nutritional factors. Epidemiol. Community Health, 52, 105-110, 1998.
15. Böing, H., Martinez, L., Frentzel-Beyme, R., and Oltersdorf, U.: Regional nutritional pattern and cancer mortality in the Federal Republic of Germany. Nutr. Cancer, 7, 121-130, 1985.
16. Adzersen, K.H., Jess, P., Freivogel, K.W., Gerhard, I., and Bastert, G.: Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany. Nutr. Cancer, 46, 131-137, 2003.
17. Kabat, G.C., Miller, A.B., Jain, M., and Rohan, T.E.: Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol. Biomarkers Prev., 16, 1306-1308, 2007.
18. Wu, T., Sempos, C.T., Freudenheim, J.L., Muti, P., and Smit, E.: Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann. Epidemiol., 14, 195-201, 2004.
19. Huang, Y.L., Sheu, J.Y., and Lin, T.H.: Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin. Biochem., 32, 131-136, 1999.
20. Chen, J., Geissler, C., Parpia, B., Li, J., and Campbell, T.C.: Antioxidant status and cancer mortality in China. Int. J. Epidemiol., 21, 625-635, 1992.
21. Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., and Hakulinen, T.: Body iron stores and risk of cancer. Int. J. Cancer, 56, 379-382, 1994.
22. Ulbrich, E.J., Lebrecht, A., Schneider, I., Ludwig, E., Koelbl, H., and Hefler, L.A.: Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res., 23, 5107-5109, 2003.
23. Cook, J.D. and Monsen, E.R.: Food iron absorption in human subjects. III. Comparison of the effect of animal proteins on nonheme iron absorption. Am. J. Clin. Nutr., 29, 859-867, 1976.
24. Monsen, E.R., Hallberg, L., Layrisse, M., Hegsted, D.M., Cook, J.D., Mertz, W., and Finch, C.A.: Estimation of available dietary iron. Am. J. Clin. Nutr., 31, 134-141, 1978.
25. Yagi, K.: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med., 15, 212-216, 1976.
26. Benzie, I.F. and Strain, J.J.: The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem., 239, 70-76, 1996.
27. Kallianpur, A.R., Hall, L.D., Yadav, M., Christman, B.W., Dittus, R.S., Haines, J.L., Parl, F.F., and Summar, M.L.: Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol. Biomarkers Prev., 13, 205-212, 2004.
28. Lee, D.H., Anderson, K.E., Harnack, L.J., and Jacobs, D.R. Jr.: Dietary iron intake and breast cancer: The Iowa Women's Health Study. Proc. Am. Assoc. Cancer Res., 45, A2319, 2004.
29. Itabe, H., Yamamoto, H., Imanaka, T., Shimamura, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y., and Takano, T.: Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid Res., 37, 45-53, 1996. (Pubitemid 26052618)
30. Schnitzer, E., Pinchuk, I., Bor, A., Fainaru, M., Samuni, A.M., and Lichtenberg, D.: Lipid oxidation in unfractionated serum and plasma. Chem. Phys. Lipids., 92, 151-170, 1998.
31. Dotan, Y., Lichtenberg, D., and Pinchuk, I.: Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog. Lipid Res., 43, 200-227, 2004.
32. Polat, M.F., Taysi, S., Gul, M., Cikman, O., Yilmaz, I., Bakan, E., and Erdogan, F.: Oxidant/antioxidant status in blood of patients with malignant breast tumour and benign breast disease. Cell Biochem. Funct., 20, 327-331, 2002.
33. Sener, D.E., Gönenç, A., Akinci, M., and Torun, M.: Lipid peroxidation and total antioxidant status in patients with breast cancer. Cell Biochem. Funct., 25, 377-382, 2007.
34. Boyd, N.F. and McGuire, V.: The possible role of lipid peroxidation in breast cancer risk. Free Radic. Biol. Med., 10, 185-190, 1991.
35. de Valk, B. and Marx, J.J.: Iron, atherosclerosis, and ischemic heart disease. Arch. Intern. Med., 159, 1542-1548, 1999.
36. Toyokuni, S., Okada, S., Hamazaki, S., Minamiyama, Y., Yamada, Y., Liang, P., Fukunaga, Y., and Midorikawa, O.: Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitriolotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res., 50, 5574-5580, 1990.
37. Toyokuni, S., Uchida, K., Okamoto, K., Hattori-Nakakuki, Y., Hiai, H., and Stadtman, E.R.: Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl. Acad. Sci. USA, 91, 2616-2620, 1994. (Pubitemid 24139398)
38. Elliott, R.L., Elliott, M.C., Wang, F., and Head, J.F.: Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann. NY Acad. Sci., 698, 159-166, 1993.
39. Ionescu, J.G., Novotny, J., Stejskal, V., Lätsch, A., Blaurock-Busch, E., and Eisenmann-Klein, M.: Increased levels of transition metals in breast cancer tissue. Neuro. Endocrinol. Lett., 27, 36-39, 2006.
40. Wyllie, S. and Liehr, J.G.: Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites: a mechanism of induction of free radical damage by estrogen. Arch. Biochem. Biophys., 346, 180-186, 1997.
41. Galaris, D., Skiada, V., and Barbouti, A.: Redox signaling and cancer: the role of "labile" iron. Cancer Lett., 266, 21-29, 2008.